Auflistung nach Autor "Forster, Michael"

Anzeige der Dokumente 1-17 von 17

An updated patent review of p38 MAP kinase inhibitors (2014-2019)

Haller, Vanessa; Nahidino, Philipp; Forster, Michael; Laufer, Stefan (2020)
Bioisosteric Replacement of Arylamide-Linked Spine Residues with N-Acylhydrazones and Selenophenes as a Design Strategy to Novel Dibenzosuberone Derivatives as Type I 1/2 p38 alpha MAP Kinase Inhibitors

Nahidino, Philipp; Kudolo, Mark; Pantsar, Tatu; Forster, Michael; Laufer, Stefan (2020)
Decisive role of water and protein dynamics in residence time of p38 alpha MAP kinase inhibitors

Pantsar, Tatu; Kaiser, Philipp D.; Kudolo, Mark; Forster, Michael; Rothbauer, Ulrich; Laufer, Stefan (2022)
Design, Synthesis and Biological Evaluation of 7-Chloro-9H-pyrimido[4,5-b]indole-based Glycogen Synthase Kinase-3 beta Inhibitors

Pantsar, Tatu; Ansideri, Francesco; Kudolo, Mark; Forster, Michael; Koch, Pierre; Andreev, Stanislav; Laufer, Stefan (2019)
Development of novel urea-based ATM kinase inhibitors with subnanomolar cellular potency and high kinome selectivity

Dimitrov, Teodor; Anli, Cetin; Moschopoulou, Athina; Kronenberger, Thales; Kudolo, Mark; Geibel, Christian; Zender, Lars; Forster, Michael; Laufer, Stefan (2022)
Development, Optimization, and Structure-Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4-d]pyrrolo[2,3-b]pyridine Scaffold

Forster, Michael; Dimitrov, Teodor; Holstein, Julia; Gehringer, Matthias; Ghoreschi, Kamran; Döring, Eva; Laufer, Stefan (2018)
Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK

Forster, Michael; Liang, Xiaojun Julia; Gerstenecker, Stefan; Laufer, Stefan; Gehringer, Matthias (2020)
Fast Iterative Synthetic Approach toward Identification of Novel Highly Selective p38 MAP Kinase Inhibitors

Kudolo, Mark; Forster, Michael; Laufer, Stefan (2019)
High-Throughput Screening Platform in Postnatal Heart Cells and Chemical Probe Toolbox to Assess Cardiomyocyte Proliferation

Forster, Michael; Laufer, Stefan (2022)
Improved Multigram Route to a Tricyclic Key Intermediate for Dibenzosuberone-Based p38 Inhibitors via an Optimized Early-Stage Heck Coupling

Forster, Michael; Wentsch-Teltschik, Heike Kristin; Laufer, Stefan (2021)
Novel Hinge-Binding Motifs for Janus Kinase 3 Inhibitors: A Comprehensive Structure-Activity Relationship Study on Tofacitinib Bioisosteres

Gehringer, Matthias; Forster, Michael; Pfaffenrot, Ellen; Bauer, Silke Mona; Laufer, Stefan (2014)
Recent advances in JAK3 inhibition: Isoform selectivity by covalent cysteine targeting

Forster, Michael; Gehringer, Matthias; Laufer, Stefan (2017)
Scaffold-Hopping-Strategie zur Entwicklung neuer kovalenter Januskinase 3 Inhibitoren mit hoher Isoform Selektivität

Forster, Michael (2018)
Selective JAK3 Inhibitors with a Covalent Reversible Binding Mode Targeting a New Induced Fit Binding Pocket

Forster, Michael; Holstein, Julia; Gehringer, Matthias; Pfaffenrot, Ellen; Ghoreschi, Kamran; Bauer, Silke Mona; Laufer, Stefan (2016)
Solution-Phase Parallel Synthesis of Ruxolitinib-Derived Janus Kinase Inhibitors via Copper-Catalyzed Azide-Alkyne Cycloaddition

Gehringer, Matthias; Forster, Michael; Laufer, Stefan (2015)
tert-Butyl N-[(3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl]-N-methylcarbamate

Gehringer, Matthias; Forster, Michael; Laufer, Stefan (2013)
Tofacitinib and analogs as inhibitors of the histone kinase PRK1 (PKN1)

Forster, Michael; Gehringer, Matthias; Pfaffenrot, Ellen; Bauer, Silke Mona; Laufer, Stefan (2016)

Anzeige der Dokumente 1-17 von 17

Veröffentlichen

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Einloggen

Auflistung nach Autor "Forster, Michael"

Auflistung nach Autor "Forster, Michael"

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Hilfe & Infos